MIAT and lung adenocarcinoma: Li et al. demonstrated that lncRNA-MIAT can act as competing endogenous RNAs (ceRNAs) to absorb miR-106 by sequence complementarity and in turn affecting miR-106′ biological functions in Lung adenocarcinoma [10].